{"nct_id":"NCT06129864","title":"A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-12-14","start_date_type":"ACTUAL","primary_completion_date":"2028-04-18","primary_completion_date_type":"ESTIMATED","completion_date":"2030-09-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}